MARKET WIRECNBC • 2h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why ATRC Stock advanced +1.73% Today — RQD Quant Desk Flash
$62.48 +1.73% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $62.56
AtriCure Inc. (ATRC) carries a Roarable Rating of C (Hold) with 63/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
ROARABLE C • HOLD / WATCH
Cap $3.18B
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $62.55 (+0.12%)🧬 Disciplined Float (+1.08% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 9% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 63/100 (C) historically posted market-perform odds over rolling 90-day windows (+0.9% avg 90D alpha vs SPY • 54.8% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →RQD QUANT TACHOMETERHOLD / WATCH • C
JEV AI Jury Split (Battleground)
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D+ · Rk B+
Each axis scored 0–20
12M PRICE TARGET CONE+2.3% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ATRC)Realized 20D OHLCV Swing Band: ±8.1%
Deterministic 5-Pillar Attribution (63/100 Composite)
🔍 WHY ATRC SCORES 63/100 (C) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+16/20 pts (25% of score)
Altman Z-Score 12.08 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9
▲ #2 Bullish Driver: Macro Regime Fit+15/20 pts (24% of score)
FRED Regime × Technicals: 99% of 52W Range • RSI-14 at 62.9 (BULLISH MOMENTUM)
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution8/20 pts (-12 pt drag)
Disciplined Float (+1.08% YoY Shares) & executive Form 4 sales trim 12 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade C$55.81+0.5% Next Q
55
Q2 (-2Q)Grade C$56.07+5.2% Next Q
58
Q3 (-1Q)Grade C$58.97+6% Next Q
60
CurrentGrade C$62.48+0.9% Hist 90D α
63
Trajectory: C (55) → C (63)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the ATRC Bull Thesis Could Fail
Even with a 63/100 (C) score, ATRC faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Company executives have done more routine share selling than personal cash buying lately.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Disciplined Float (+1.08% YoY Shares) — any gross margin slip below 72.5% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($55.58) or 200D SMA ($38.09) invalidates the momentum regime and cuts Target Base ($63.89) toward Bear Floor ($49.83).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $ATRC• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “ATRC Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why ATRC Stock advanced +1.73% Today — RQD Quant Desk Flash
AtriCure Inc. (ATRC) advanced +1.73% to $62.48, trading at 99% of its 52-week range ($25.36 – $63). Solid 75% profit margin (-2% return on capital), mixed timing at current multiples—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 99% of its 52-week range ($25.36 – $63) with RSI-14 at 62.9 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±8.1% around $62.48 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable C (Hold) backed by 75% gross margin and $48.3M annual free cash flow.
Live ATRC Headlines & Catalysts
MARKET WIRECNBC • 3h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 4h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 5h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 6h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 7h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 7h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 7h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk
Scheduled RQD Strong Buys & Whale Accumulation Briefing (ATRC Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
ATRC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +122.27%▲ ASCENDING CHANNEL
2026-10-30O $62.41H $62.48L $59.70C $62.48VOL 966.4K
RES: $71.12SUP: $57.48SMA50: $55.58SMA200: $38.09
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
ATRC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +14.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on ATRC today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for ATRC. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ATRC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ATRC)
Health Care Rank #156 of 1016
⚔️ NVST vs ATRC Full Matrix →
1. Head-to-Head Health Care Peer Comparison (ATRC vs. NVST, PLSE, IRTC, ICUI)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, AtriCure Inc. (ATRC) ranks #156 by composite RQD confidence (63/100, grade C) and #203 by equity capitalization ($3.18B). Within this direct 5-issuer industry benchmark cohort, NVST leads on earnings valuation at 84.1x trailing P/E, while NVST leads on capital efficiency and profitability with 5.1% ROIC and 54.7% gross margin. ATRC currently leads its immediate peer cohort in composite quantitative strength at 63/100 (C).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| ATRC
ACTIVE
AtriCure Inc. | C | 63/100 | — | 75.0% | -1.9% | +1.73% | $3.18B | Benchmark Subject |
| NVST Envista Holdings Corporation | D | 49/100 | 84.1x | 54.7% | 5.1% | +2.80% | $3.95B | /nvst-vs-atrc → |
| PLSE Pulse Biosciences Inc | D- | 41/100 | — | -30.0% | -30.7% | +3.37% | $3.96B | /plse-vs-atrc → |
| IRTC iRhythm Holdings Inc. | D | 48/100 | — | 70.6% | -13.5% | +3.07% | $4.21B | /irtc-vs-atrc → |
| ICUI ICU Medical Inc. | D+ | 55/100 | — | 36.8% | 1.0% | +1.36% | $4.22B | /icui-vs-atrc → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001323885In its most recent audited fiscal period (FY2025, filed 2025-12-31), AtriCure Inc. (ATRC) reported GAAP revenue of $534.5M (+14.9% vs. FY2024 revenue of $465.3M , and +33.9% cumulative change since FY2023) , GAAP net income of -$11.4M, operating cash flow of $57.3M, and free cash flow of $48.3M (+6381.1% YoY). On the balance sheet, ATRC closed FY2025 with $654.2M in total assets against $61.9M in total debt (Altman Z-Score: 12.08, Piotroski F-Score: 8/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $534.5M | -$11.4M | $57.3M | $48.3M | $654.2M | $61.9M |
| FY2024 (FY) | 2024-12-31 | $465.3M | -$44.7M | $12.2M | $745.0K | $609.3M | $61.9M |
| FY2023 (FY) | 2023-12-31 | $399.2M | -$30.4M | $4.5M | $4.5M | — | — |
3. ATRC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs ATRC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, AtriCure Inc. (NASDAQ: ATRC) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 63/100 at a spot price of $62.48 (+1.73% 1D, market cap $3.18B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 8/20. Across 1016 tracked Health Care issuers, ATRC ranks #156 in composite RQD confidence.
How does ATRC compare to NVST and PLSE in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), ATRC carries a Roarable C (63/100 RQD), trailing P/E of N/A, gross margin of 75.0%, and ROIC of -1.9%. By comparison, NVST (Envista Holdings Corporation) holds a D grade (49/100 RQD, P/E 84.1x, ROIC 5.1%, cap $3.95B) and PLSE (Pulse Biosciences Inc) posts a D- grade (41/100 RQD, P/E N/A, ROIC -30.7%, cap $3.96B). Among the 5-stock peer group, NVST leads on earnings multiple (84.1x) while NVST leads on capital efficiency (5.1% ROIC).
What are the biggest fundamental strengths and SEC risk factors for ATRC?
Per ATRC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001323885), AtriCure Inc. generated $534.5M in revenue (+14.9% YoY), -$11.4M in net income, and $48.3M in free cash flow against $654.2M in total assets and $61.9M in total debt. Key quantitative strengths: Clean SEC annual filing review with no major hidden accounting time-bombs.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is ATRC trading relative to its 50-day, 200-day, and 52-week technical levels?
ATRC last traded at $62.48 (+1.73% on volume of 702,406 shares), positioning the stock +12.41% above its 50-day simple moving average ($55.58) and +64.03% above its 200-day simple moving average ($38.09). Across its 52-week range of $25.36 to $63.00, ATRC sits at the 98.6% percentile with a 14-day RSI of 62.9 (BULLISH MOMENTUM) and an implied next-earnings move of ±8.1% ($57.42 to $67.54).
ATRC Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is ATRC stock moving today?
Why ATRC Stock advanced +1.73% Today — RQD Quant Desk Flash. Solid 75% profit margin (-2% return on capital), mixed timing at current multiples—hold if owned, no rush to chase.